RE:RE:RE:RE:RE:Wowmenoalittle wrote: yeah, very interesting developments today for sure...
lots of newbies buy TLT looking for some hot trading action related to COVID-19...
professional shorting wolf packs see it as hype and short the chit out it...
volume and % gain in stock draws national news and interest to TLT the next day or two...
newbies hear and read more... suddenly realize TLT has probable cure for cancer...
newbies, realizing they've accidentally stumbled into something great, rush to buy up more TLT...
began telling friends & family... who also rush in to buy more...
old time TLT stock holders (who know what they have) refuse to sell any...
continued rise in price and volume draws more national news coverage...
pro short wolf packs chit their drawers, began to panic buy attempting to cover big losses...
oh my... starts a vicious upward spiral...
(to the moon, Alice... to the moon.)
Well said...poor chaps had no idea what was coming. It was only a matter of time....as I emphasized to Goldy in my last post ; ) Important point: When a compound like this starts getting independently verified by multiple independent sources across multiple indications, you're getting very close to raising the checkered flag. This is a "major" milestone & the de risk has been elevated to a new level. Shorters beware...
Dr. Coombs was able to prove high efficacy amongst "more than one" & "unrelated" enveloped viruses (a flu strain & Zika). The clinical significance of this discovery & TLD1433's potential use as a "general antiviral" is enormous. Think of the "numerous" other enveloped viruses that cause significant human disease, many of which have devastating human/economic impacts despite available therapies (coronavirus, paramyxovirus, herpes virus, hepatitis virus, dengue/flavivirus & HIV to name a few). RPCCC, UM & many more to come Goldy ; ). Very exciting...good luck all.